Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Hepatocellular × Capecitabine × Clear all

Phase

Status

Completed 14 Unknown 4 Terminated 3 Not yet recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Colorectal Neoplasms 8 Rectal Neoplasms 6 Pancreatic Neoplasms 4 Colorectal Cancer Metastatic 4 Neoplasm Metastasis 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Gallbladder Neoplasms 2 Carcinoma, Merkel Cell 2 Biliary Tract Neoplasms 2 Zollinger-Ellison Syndrome 1 Vipoma 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1

Interventions

Sorafenib 11 lenvatinib 7 Radiosurgery 7 spartalizumab 6 Oxaliplatin 6 Fluorouracil 5 Radiotherapy 4 Leucovorin 3 Gemcitabine 3 Folfox protocol 3 Doxorubicin 3 fludarabine 2 cabozantinib 2 Nivolumab 2 Mitomycin 2 Electroporation 2 Cyclophosphamide 2 Cisplatin 2 Chemoembolization, Therapeutic 2 Bevacizumab 2 tremelimumab 1 toripalimab 1 tocilizumab 1 temsirolimus 1 tazemetostat 1 pirarubicin 1 perflutren 1 pembrolizumab 1 maltodextrin 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01245582 2011-11-09

SECOX

Sanofi

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡